HIV Self-Testing

HIV testing is key to controlling the transmission of HIV. If people cannot get to a medical care provider or community-based organization for HIV testing, Piedmont Care is offering an FDA-approved at-home, self-administered HIV testing option. The CDC is recommending that community-based organizations, like Piedmont Care, consider at-home, self-administered HIV testing as an additional strategy to reach those most affected by HIV, since traditional HIV testing services may be interrupted due to the COVID-19 response.  

The self-administered home HIV test requires no blood and offers results in 20 minutes. People qualifying for the self-testing option will also have access to a 24/7 call center and video guide to get answers quickly.  

The Piedmont Care team will also provide:  

  • Linkage to care services for people living with HIV
  • Follow-up planning and resources
  • Condoms and other HIV prevention tools

To see if you qualify to receive an at-home HIV test kit, click here.

Watch this short video to help guide you through taking your OraQuick test in a few short minutes.

Piedmont Care's at-home HIV testing program is supported by donations. The pilot program is supported by the Kaiser Family Foundation, Walgreens, and the Mary Black Foundation.

On-Site Testing Facility

Piedmont Care, Inc.

101 North Pine Street, Suite 200 (Wells Fargo Building), Spartanburg, SC 29302

(864) 582-7773 or (866) 454-7773

Office Hours:
Monday – Friday, 8:30am – 5:00pm  

Testing Hours:
Monday / Tuesday / Thursday / Friday: 8:30am – 3:30pm  
Wednesday: 8:30 a.m. – Noon


Type of Test:
OraQuick Rapid test - same day results

Test Procedure:
Oral swab-upper and lower gums using a testing device

Additional Info:
All individuals receiving this test must receive counseling before being tested and upon receiving their test results. Counseling includes: The importance of HIV testing, Basic HIV/AIDS knowledge assessment, risk reduction plan, condom demonstration, next steps if preliminary positive result, recommendation for follow-up testing.